Rare diseases
Investigational molecules
Locations
Vetenskapens Grand 11, Fassberg, 431 53 Molndal, Sweden
Research activity includes therapies for chronic hepatitis D virus infection, with interest in viral RNA reduction and treatment options for persistent HDV infection.
The sponsor’s work in this area is centered on hepatology and the management of viral liver disease.
Ribocure Pharmaceuticals AB runs clinical trials in conditions such as Coronary artery disease, Dyslipidaemia, Atrial fibrillation, Embolism venous, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness
PolandSafety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
PolandSafety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study
DenmarkSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
BulgariaStudy on the Effects of RBD1016 and Tenofovir Alafenamide for Patients with Chronic Hepatitis D Infection
SwedenStudy of RBD4059 and acetylsalicylic acid in patients with stable coronary artery disease: evaluation of safety and drug behavior in the body
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
